Restenosis after infrapopliteal angioplasty - clinical importance, study update and further directions

Frederic Baumann1, Nicolas Diehm

  • 1Department of Clinical and Interventional Angiology, Swiss Cardiovascular Center, Inselspital, University Hospital of Bern, Switzerland.

Insights

Critical limb ischemia (CLI) patients face high mortality from peripheral arterial disease (PAD). Understanding tibial restenosis pathophysiology and developing new strategies are crucial for improving outcomes in these challenging cases.

Area of Science:

  • Vascular Medicine
  • Interventional Cardiology
  • Regenerative Medicine

Background:

  • Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease (PAD), associated with high mortality rates.
  • Infrapopliteal arterial disease is common in CLI patients, posing challenges for endovascular revascularization.
  • Restenosis after tibial angioplasty significantly impacts clinical outcomes, affecting over two-thirds of CLI patients.

Purpose of the Study:

  • To provide an updated review of the pathophysiology of tibial restenosis.
  • To discuss current and emerging antirestenosis strategies for tibial angioplasty in CLI patients.

Main Methods:

  • Literature review of studies on tibial restenosis in critical limb ischemia.
  • Analysis of current clinical trials investigating antirestenosis concepts.
  • Synthesis of knowledge from coronary artery research applied to tibial arteries.

Main Results:

  • Tibial patency is essential for optimal clinical outcomes in CLI patients post-angioplasty.
  • The precise pathophysiological mechanisms of tibial restenosis are not fully understood.
  • Multiple strategies are under investigation to mitigate tibial restenosis.

Conclusions:

  • Further research into the specific pathophysiology of tibial restenosis is warranted.
  • Developing effective antirestenosis strategies is critical for improving CLI patient prognosis.
  • Optimizing tibial angioplasty outcomes requires a comprehensive understanding of restenosis mechanisms.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
637
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
663